Lisa Defrancesco
SVP, IR & Corp. Affairs, Intercept Pharmaceuticals.
Companies
- Lexicon PharmaceuticalsVP, IR and Corp Strategy Oct 7, 2024 to now1
- Intercept PharmaceuticalsSVP, IR & Corp. Affairs Feb 17, 2021 to Jan 4, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lexicon Pharmaceuticals LXRX93,869 shares3$146.9K at $1.56Feb 28, 2026
Intercept Pharmaceuticals ICPT10,308 shares4Dec 31, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 28, 2026Shares withheld for tax 74,572 shares at $1.47 of Lexicon Pharmaceuticals3
- Feb 28, 2026Exercised options 128,190 shares of Lexicon Pharmaceuticals3
- Feb 28, 2026Exercised options 24,674 shares of Lexicon Pharmaceuticals3
- Feb 28, 2025Shares withheld for tax 9,096 shares at $0.67 of Lexicon Pharmaceuticals5
- Feb 28, 2025Exercised options 24,673 shares of Lexicon Pharmaceuticals5
- Dec 31, 2021Shares withheld for tax 542 shares at $16.29 of Intercept Pharmaceuticals4
- Sep 30, 2021Shares withheld for tax 204 shares at $14.85 of Intercept Pharmaceuticals6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Mar 3, 2025
- 6SEC EDGARForm 4 filed Oct 4, 2021